Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were significantly more likely to be prescribed guideline-recommended high-intensity statin therapy ...

How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to ...

CHICAGO, IL – It's been a full 365 days since the American College of Cardiology (ACC) and American Heart Association (AHA) presented their "paradigm-shifting" clinical guidelines for the management ...

Please provide your email address to receive an email when new articles are posted on . “Individuals with severe hypercholesterolemia have a fivefold higher long-term risk for coronary heart disease ...

Email reminders to physicians about proper dosing of high-intensity statins, individualized to specific patients and often timed around their appointments, significantly improved the likelihood of ...

Two new studies published this week highlight the successes, as well as the disappointments, in the battle to get patients to take a high-intensity statin for secondary prevention. In the “good news” ...

From 2011 to 2014 the use of high-intensity statins following hospitalization for myocardial infarction (MI) increased progressively, according to a study published in Journal of the American College ...

Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater ...

Patients with established clinical ASCVD Patients with severe primary hypercholesterolemia (a baseline LDL-C level ≥190 mg/dL) Patients 40-75 years of age with diabetes and a baseline LDL-C level of ...

The United States Preventive Services Task Force has released new guidance for prescribing statins for patients with no history of cardiovascular disease (primary prevention), The update is based on ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population. Last year, an HHS panel ...